• Godavari Drugs Ltd board meeting scheduled for May 27, 2026 to approve audited standalone financial results for Q4 and FY ended March 31, 2026.
• Trading window for insiders closed since April 1, 2026 and will reopen 48 hours after financial results declaration.
• Disclosure made pursuant to SEBI Listing Regulations Regulation 29(1)(a) and Companies Act provisions.